Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership5,683 shares
Latest Disclosed Value $ 5,227,053
Pinnacle Bancorp, Inc. reports 2.99% increase in ownership of LLY / Eli Lilly and Company

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 5,683 shares of Eli Lilly and Company (US:LLY) valued at $5,227,053 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 5,518 shares of Eli Lilly and Company. This represents a change in shares of 2.99% during the quarter. The current value of the position is $6,130,707 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Eli Lilly & Co Com COM 532457108 5,683 165 2.99 5,227 -11.85 1.5426
2026-01-22 2025-12-31 13F Eli Lilly & Co Com COM 532457108 5,518 -9 -0.16 5,930 40.62 1.7382
2025-10-24 2025-09-30 13F Eli Lilly & Co Com COM 532457108 5,527 163 3.04 4,217 0.86 1.2456
2025-07-11 2025-06-30 13F Eli Lilly & Co Com COM 532457108 5,364 60 1.13 4,181 -4.54 1.2904
2025-04-23 2025-03-31 13F Eli Lilly & Co Com COM 532457108 5,304 35 0.66 4,381 7.70 1.4282
2025-01-14 2024-12-31 13F Eli Lilly & Co Com COM 532457108 5,269 46 0.88 4,068 -12.10 1.3229
2024-10-09 2024-09-30 13F Eli Lilly & Co Com COM 532457108 5,223 0 0.00 4,627 -2.14 1.2371
2024-07-15 2024-06-30 13F Eli Lilly & Co Com COM 532457108 5,223 -30 -0.57 4,729 15.71 1.3963
2024-04-16 2024-03-31 13F Eli Lilly & Co Com COM 532457108 5,253 0 0.00 4,087 33.44 1.2087
2024-01-25 2023-12-31 13F Eli Lilly & Co Com COM 532457108 5,253 -25 -0.47 3,062 8.05 1.0024
2023-10-18 2023-09-30 13F Eli Lilly & Co Com COM 532457108 5,278 -1,551 -22.71 2,835 -11.49 1.0076
2023-07-14 2023-06-30 13F Eli Lilly & Co Com COM 532457108 6,829 -15 -0.22 3,203 36.26 1.0950
2023-04-14 2023-03-31 13F Eli Lilly & Co Com COM 532457108 6,844 193 2.90 2,350 117,400.00 0.8627
2023-01-24 2022-12-31 13F Eli Lilly & Co Com COM 532457108 6,651 11 0.17 2 -99.91 0.9360
2022-10-25 2022-09-30 13F Eli Lilly & Co Com COM 532457108 6,640 297 4.68 2,147 4.38 0.9271
2022-07-12 2022-06-30 13F Eli Lilly & Co Com COM 532457108 6,343 1,177 22.78 2,057 39.08 0.8464
2022-04-14 2022-03-31 13F Eli Lilly & Co Com COM 532457108 5,166 -20 -0.39 1,479 3.28 0.5132
2022-01-19 2021-12-31 13F Eli Lilly & Co Com COM 532457108 5,186 -180 -3.35 1,432 15.48 0.5062
2021-10-12 2021-09-30 13F Eli Lilly & Co Com COM 532457108 5,366 95 1.80 1,240 2.48 0.4958
2021-07-15 2021-06-30 13F Eli Lilly & Co Com COM 532457108 5,271 0 0.00 1,210 22.84 0.5521
2021-04-26 2021-03-31 13F Eli Lilly & Co Com COM 532457108 5,271 -85 -1.59 985 8.96 0.4773
2021-01-13 2020-12-31 13F Eli Lilly & Co Com COM 532457108 5,356 0 0.00 904 14.00 0.5568
2020-10-13 2020-09-30 13F Eli Lilly & Co Com COM 532457108 5,356 0 0.00 793 -9.78 0.5590
2020-07-07 2020-06-30 13F Eli Lilly & Co Com COM 532457108 5,356 -10 -0.19 879 18.15 0.6538
2020-04-09 2020-03-31 13F Eli Lilly & Co Com COM 532457108 5,366 -40 -0.74 744 4.64 0.6355
2020-01-10 2019-12-31 13F Eli Lilly & Co Com COM 532457108 5,406 0 0.00 711 17.52 0.4926
2019-10-08 2019-09-30 13F Eli Lilly & Co Com COM 532457108 5,406 0 0.00 605 1.00 0.3454
2019-07-08 2019-06-30 13F Eli Lilly & Co Com COM 532457108 5,406 0 0.00 599 -14.55 0.3367
2019-04-05 2019-03-31 13F Eli Lilly & Co Com COM 532457108 5,406 -80 -1.46 701 10.39 0.4066
2019-03-20 2018-12-31 13F Eli Lilly & Co Com COM 532457108 5,486 35 0.64 635 38.65 0.3906
2017-04-17 2017-03-31 13F Eli Lilly & Co Com COM 532457108 5,451 5,451 458 0.3238
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.